We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Cell Sorting System Developed for Advanced Life Science Research Applications

By LabMedica International staff writers
Posted on 19 May 2010
An advanced high-speed cell sorter that can support up to seven lasers and six-way sorting with new software and a range of flexible capabilities is now available for purchase by life science researchers.

The new Influx cell sorting system is manufactured by BD Biosiences, a segment of Becton, Dickinson and Company (Franklin Lakes, NJ, USA). More...
It was designed according to a scheme of modular architecture based on exchangeable detector options, hands-on controls, and sorting options that make it adaptable to a wide variety of site and application needs. The seven laser paths and seven-pinhole optical collection system in the Influx system supports 24 parameters simultaneously with a 24 x 24 compensation matrix.

The Influx system uses parallel electronics to reach a throughput rate of 200,000 events per second, independent of the number of lasers or parameters. Its fluidics design features a special acoustical coupling in the nozzle assembly to create droplets for sorting, while ensuring low shear stress to optimize cell viability, even at high pressures. Disposable fluidics allows the easy replacement of a sample line or the complete fluidics path from sheath tank to nozzle tip in order to maintain strict aseptic cell sorting.

A new dedicated software package uses industry-standard protocols to manage hundreds of system parameters, giving investigators a high level of control and engagement with the instrument to support advanced research applications. Software wizards and controls will assist investigators in classifying cell populations, performing compensation, monitoring sorting and analyzing results.

"Life science researchers on the vanguard of cellular analysis require flexible cell sorting systems to meet their ever-complex needs,” said James Glasscock, president, cell analysis at BD Biosciences. "The new BD Influx system rises to that challenge and is already in use in a leading institution performing advanced cell research.”

Related Links:

Becton, Dickinson and Company



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.